Biognosys

Transforming life sciences with cutting-edge #proteomics technology and solutions

[Biognosys @biognosys]

📍Heading to #AACR2026?
The Biognosys Group will be there, showcasing our integrated #multiomics CRO services – combining #proteomics, #metabolomics, and #lipidomics to drive deeper insights in #CancerResearch and #DrugDiscovery.

👉 Learn more: https://t.co/qR0BbJbTND

[Biognosys @biognosys]

We are on site at #ADPD2026 and ready to present our poster today at lunchtime! 📊

“Identifying Circulating #Biomarkers for Amyloid Conversion and Early Cognitive Decline in Matched CSF and #Plasma through Unbiased #Proteomics”

If you’re attending, make sure to stop by! 🤝

[Biognosys @biognosys]

📍Attending #ADPD2026?
Don’t miss our poster to explore how unbiased #proteomics can help identify circulating #biomarkers for amyloid conversion and early cognitive decline using matched CSF and #plasma.

📅March 18, 12:50-14:30
📌01-447

We look forward to discussing the work!

[Biognosys @biognosys]

🧑‍🚀🚀Are you based in Boston and want to learn more about #Spectronaut?

Then join our Spectronaut User Meeting at the @broadinstitute!

📅 April 8, 2026
📍 the Broad Institute, Cambridge, MA

👉 Learn more & register: https://t.co/oI1Indr5OF

#MassSpectrometry #DIAproteomics

[Biognosys @biognosys]

📍 We’re onsite at #USHUPO2026 in St. Louis and ready to connect! 👋

Stop by Booth #14 to meet our experts and learn how our #proteomics solutions can support your research - from sample preparation to advanced data analysis.

Learn more: https://t.co/UhzGZKR4H2

[Biognosys @biognosys]

Join us at the 3rd International Cancer Neuroscience Symposium in Houston!

Visit our booth to learn how #proteomics can advance your cancer research or book a meeting with one of our experts.

👉 Schedule a meeting: https://t.co/GLphmXuPw5

#CancerNeuroscience #OncologyResearch

[Biognosys @biognosys]

🎥 New Spectronaut Tutorial: Analyzing DIA Data from Isotopically Labeled Samples

In this tutorial, we walk through how to analyze DIA data from labeled workflows, including pulsed SILAC and heavy spike-in peptides.

👉 Watch the tutorial: https://t.co/H5fnREd2X5

#DIAproteomics

[Biognosys @biognosys]

We’re heading to #USHUPO2026 in St. Louis, MO and we truly can’t wait to be there.

🔬 Looking to explore what’s next in #proteomics?
📍 Join our experts at Booth 14 or our posters to discuss how we can move your research forward together.

Learn more: https://t.co/UhzGZKRCwA

[Biognosys @biognosys]

In our latest blog, we speak with Daniel Green, Head of Bioinformatics at Greywolf Therapeutics, about how his team uses #immunopeptidomics across the drug development pipeline. 💊

👉 Read the full interview here: https://t.co/KcyqLHqJTz

#DrugDiscovery #Proteomics

[Biognosys @biognosys]

🔍 Explore how our proteomics software helped unlock biological insight in 2025!

👉 Read the full blog here: https://t.co/ilr5xwoUek

#Proteomics #MassSpectrometry #DIAproteomics

[Biognosys @biognosys]

TrueTarget LiP-MS enables unbiased, proteome-wide target identification and binding-site mapping directly in complex cellular environments - without the need for compound modification or protein purification.

Explore our poster to learn more: https://t.co/TBMouQ2mc4

[Biognosys @biognosys]

🎉Congratulations to the team from @helsinkiuni!

In their recent study, the authors report preliminary data showing that the P2 and P2-iST Plasma kits delivered the highest plasma proteome coverage compared with other plasma enrichment approaches.

https://t.co/SU2WSz85k1

[Biognosys @biognosys]

We hope this holiday season gives you time to step back, recharge, and enjoy meaningful moments with the people who matter most.

Thank you for being part of our journey. We look forward to pushing the boundaries of proteomics in 2026!🌟

[Biognosys @biognosys]

Our two-step LC-MS approach integrates automated bottom-up sample preparation with heavy-labeled peptide spike-in, and is validated across 10 preclinical and clinical degraders targeting 6 disease-relevant proteins.

👉 Download the poster: https://t.co/VJEj1mkHFU

#Proteomics

[Biognosys @biognosys]

The Digital Proteome is a multi-species protein expression atlas designed to support #TargetDiscovery and validation. It enables a richer understanding of target accessibility, off-target liabilities, and pathway coverage.

👉Download the poster: https://t.co/RgytplYO25

[Biognosys @biognosys]

We recently introduced OmicsFlow, Biognosys’ new cloud-native platform that enables users to orchestrate high-throughput proteomics workflows at scale.

👉 Download the poster to learn more: https://t.co/2F3GLkvbxw

#OmicsFlow #CloudComputing #OmicsDataAnalysis

[Biognosys @biognosys]

In our #HUPO2025 poster, we highlight:
🩸Robustness and quantitative precision of our P2 workflow
🩸 Quantitative accuracy across different acquisition throughputs
🩸 Improved detection of lower-abundance proteins

👉 Download the poster: https://t.co/C6HuA2uNGg
#PlasmaProteomics

[Biognosys @biognosys]

This week at the European Bioanalysis Forum in Barcelona, Luca Raess presented our latest work on ultra-sensitive quantification of UBE3A in human CSF.

Check out the poster:

🔗https://t.co/kW4idswsP8

#Bioanalytics #MassSpec #SISCAPA #AngelmanSyndrome #Proteomics

[Biognosys @biognosys]

🎥We’re thrilled to introduce OmicsFlow, Biognosys’ new cloud platform, presented by Damiano Robbiani at #HUPO2025.

🚀 #OmicsFlow makes it simple to run #Spectronaut in parallel, in the cloud — turning days of computation into hours.

🔬 Learn more: https://t.co/3CWrd1oqP9

[Biognosys @biognosys]

It’s the last day at #HUPO2025, but we’re not slowing down!🚀

We're ready to share five more posters, covering the latest in #Spectronaut, #BiomarkerDiscovery, #immunopeptidomics and more!

You can already download our Monday and Tuesday posters here 👉 https://t.co/ZoiOCV9Xcy